Home > Insider Trading > Filing (0000950170-23-038564)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661998	Homology Medicines Inc.	FIXX	Pharmaceutical Preparations (2834)	473468154

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1968554	Julie Jordan	C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-02	350	$0.00	2,869	No	4	M	Direct
Common Stock	Disposition	2023-08-02	99	$1.31	2,770	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-08-02	350	$0.00	350	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
The restricted stock units vested and settled in full on August 2, 2023.